|
|
||||||||
Dr. Silver is Assistant Clinical Professor of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Conn.
Reprint requests: Dr. Silver, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, One Long Wharf Drive, New Haven, CT 06511.
"Ergogenic aid" is defined as any means of enhancing energy utilization, including energy production, control, and efficiency. Athletes frequently use ergogenic aids to improve their performance and increase their chances of winning in competition. It is estimated that between 1 and 3 million male and female athletes in the United States alone have used anabolic steroids. In response to the problem of drug use, many athletic organizations have established policies prohibiting the use of certain pharmacologic, physiologic, and nutritional aids by athletes and have implemented drug testing programs to monitor compliance. Therefore, it is important for physicians to be knowledgeable about the available ergogenic aids so they can appropriately treat and counsel the athletic patient.
This article has been cited by other articles:
![]() |
V J Dalbo, M D Roberts, J R Stout, and C M Kerksick Putting to rest the myth of creatine supplementation leading to muscle cramps and dehydration Br. J. Sports Med., July 1, 2008; 42(7): 567 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Calfee and P. Fadale Popular Ergogenic Drugs and Supplements in Young Athletes Pediatrics, March 1, 2006; 117(3): e577 - e589. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Hornsby Jr. and R. D. Chetlin Management of Competitive Athletes With Diabetes Diabetes Spectr, April 1, 2005; 18(2): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tokish, M. S. Kocher, and R. J. Hawkins Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports Am. J. Sports Med., September 1, 2004; 32(6): 1543 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Boyce Use and Effectiveness of Performance-Enhancing Substances Journal of Pharmacy Practice, February 1, 2003; 16(1): 22 - 36. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |